Mercedes Garayoa

8PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyMolecular medicineMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2024
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands.

Andrea Díaz-Tejedor, Javier Rodríguez-Ubreva, Laura Ciudad

|Jun 02, 2021
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.

Patricia Maiso, Pedro Mogollón, Enrique M Ocio

|Apr 03, 2021
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma.

Esperanza M Algarín, Dalia Quwaider, Francisco J Campos-Laborie

|Apr 03, 2021
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression.

Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig

|Jan 19, 2021
Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease.

Antonio Garcia-Gomez, Tianlu Li, Carlos de la Calle-Fabregat

|Sep 29, 2020
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma.

Teresa Paíno, Lorena González-Méndez, Laura San-Segundo

Pageof 2

Frequent Collaborators

5 joint publications

Teresa Paíno

5 joint publications

Enrique M Ocio

4 joint publications

Pedro Mogollón

4 joint publications

Andrea Díaz-Tejedor